You have 9 free searches left this month | for more free features.

MC4R

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

Recruiting
  • Leukemia
  • +3 more
  • MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
  • Amsterdam, Netherlands
  • +4 more
Jan 4, 2023

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

Hyalo4 Skin in Acute and Chronic Wounds

Recruiting
  • Wound Heal
  • Hyalo4 Skin Gel
  • Bratislava, Slovakia
  • +5 more
Oct 26, 2023

Rheumatoid Arthritis Trial in Worldwide (MSB11456, EU-approved RoActemra)

Completed
  • Rheumatoid Arthritis
  • Haskovo, Khaskovo, Bulgaria
  • +81 more
Jun 20, 2022

Erosive Esophagitis Trial in Worldwide (X842, X842 Dummy, Lansoprazole)

Recruiting
  • Erosive Esophagitis
  • DeBary, Florida
  • +66 more
Jun 10, 2022

The Examination of Woman Generations' on Exercise Preferences,

Not yet recruiting
  • Healthy Woman
  • Body Image
  • Assessment1
  • +4 more
  • (no location specified)
Jun 18, 2023

Safety, Pharmacokinetics Trial in Sofia (single E4 30 mg, single E4 100 mg, multiple E4 100 mg)

Recruiting
  • Safety
  • Pharmacokinetics
  • single E4 30 mg
  • +3 more
  • Sofia, Bulgaria
    MC Comac Medical Ltd
Jul 12, 2022

Metastatic Colorectal Cancer Trial in Worldwide (Encorafenib, Cetuximab, Pembrolizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +91 more
Jan 25, 2023

Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

Not yet recruiting
  • Pneumococcal Vaccines
  • IVT PCV-25 Formulation A
  • +3 more
  • Vancouver, British Columbia, Canada
  • +3 more
Oct 10, 2023

Psoriasis Trial in Canada, Japan, United States (Cedirogant, Placebo)

Recruiting
  • Psoriasis
  • Birmingham, Alabama
  • +54 more
Aug 4, 2022

Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Obesity
  • Caba, Buenos Aires, Argentina
  • +48 more
Sep 8, 2023

IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With

Not yet recruiting
  • Chronic Rhino-sinusitis
  • +3 more
  • IL-4R
  • Placebo
  • Beijing, Beijing, China
    Beijing Tongren Hospital, Capital Medical University
Jun 17, 2022

Primary Knee Osteoarthritis Grade 3 - 4 Trial in Tbilisi (Lipocet® (food supplement), Lipocet Placebo)

Completed
  • Primary Knee Osteoarthritis Grade 3 - 4
  • Lipocet® (food supplement)
  • Lipocet Placebo
  • Tbilisi, Georgia
  • +2 more
Nov 10, 2023

COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

Recruiting
  • COVID-19
  • Calgary, Alberta, Canada
  • +56 more
Jan 12, 2023

Healthy Aging Trial in Sherbrooke (2 months of reduced carb menus)

Not yet recruiting
  • Healthy Aging
  • 2 months of reduced carb menus
  • Sherbrooke, Quebec, Canada
    Research Center on Aging
Aug 30, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial (LILRB4 STAR-T cells)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • LILRB4 STAR-T cells
  • (no location specified)
Sep 16, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Dalpiciclib Isetionate Tablets, Camrelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Dalpiciclib Isetionate Tablets, Camrelizumab
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2023

Uterine Fibroids Trial in Worldwide (Vilaprisan (BAY1002670))

Completed
  • Uterine Fibroids
  • Vilaprisan (BAY1002670)
  • Blacktown, New South Wales, Australia
  • +139 more
Oct 29, 2021

Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-9003)

Enrolling by invitation
  • Limb Girdle Muscular Dystrophy
  • SRP-9003
  • Columbus, Ohio
    Nationwide Children's Hospital
May 17, 2023

Aging Trial in Glendale

Withdrawn
  • Aging
  • (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
  • Control
  • Glendale, Arizona
    Glencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023

Schizophrenia Trial in Rwanda (Risperidone 3 mg, Paliperidone Palmitate 50 mg eq., Paliperidone Palmitate 75 mg eq.)

Recruiting
  • Schizophrenia
  • Risperidone 3 mg
  • +8 more
  • Butare, Rwanda
  • +4 more
Jan 3, 2023

Superficial Digital Flexor Tendonitis Trial in Zürich (Genipin)

Completed
  • Superficial Digital Flexor Tendonitis
  • Zürich, ZH, Switzerland
    Equine surgery, Vetsuisse-Faculty, University of Zurich
Feb 22, 2023

Dementia Trial in Oakville, Toronto (Immersive VR Therapy in Head-Mounted Device (HMD))

Not yet recruiting
  • Dementia
  • Immersive VR Therapy in Head-Mounted Device (HMD)
  • Oakville, Ontario, Canada
  • +3 more
May 10, 2023

Healthy Volunteers Trial in Neuss (Biocon's Human Insulin R U-500, Humulin® R U-500 (US Reference Product))

Recruiting
  • Healthy Volunteers
  • Biocon's Human Insulin R U-500
  • Humulin® R U-500 (US Reference Product)
  • Neuss, Germany
    Profil Institut für Stoffwechselforschung GmbH 9
Jun 9, 2022

COVID-19 Trial in Campos Dos Goytacazes (AZVUDINE, AZVUDINE )

Completed
  • COVID-19
  • Campos Dos Goytacazes, RJ, Brazil
    Santa Casa de Misericordia de Campos
Aug 10, 2022